Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005797
Filing Date
2014-11-14
Accepted
2014-11-14 14:53:55
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kite-10q_20140930.htm 10-Q 1788267
2 EX-31.1 kite-ex311_201409309.htm EX-31.1 8476
3 EX-31.2 kite-ex312_2014093011.htm EX-31.2 8469
4 EX-32.1 kite-ex321_2014093010.htm EX-32.1 6378
5 EX-32.2 kite-ex322_201409307.htm EX-32.2 6361
  Complete submission text file 0001564590-14-005797.txt   10021858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kite-20140930.xml EX-101.INS 1713753
7 XBRL TAXONOMY EXTENSION SCHEMA kite-20140930.xsd EX-101.SCH 52430
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kite-20140930_cal.xml EX-101.CAL 40809
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kite-20140930_def.xml EX-101.DEF 200194
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kite-20140930_lab.xml EX-101.LAB 439818
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kite-20140930_pre.xml EX-101.PRE 330039
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36508 | Film No.: 141223213
SIC: 2836 Biological Products, (No Diagnostic Substances)